Cumulus Oncology
Business Services · United Kingdom · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Wework 80 George St, Edinburgh, Midlothi...Website
www.cumulusoncology.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
2
1
1
1
1
About Cumulus Oncology
Cumulus Oncology focuses on transforming oncology drug development by creating a risk-adjusted asset portfolio aimed at improving patient outcomes. Their approach emphasizes data-driven, milestone-based decision-making to enhance the success rates of preclinical-stage assets as they progress to later stages. The company actively curates its portfolio through strategic partnerships and proactive asset sourcing, targeting high-value opportunities in defined patient populations with unmet medical needs. Cumulus aims to drive value creation and exit opportunities for investors by managing risk and reward effectively.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cumulus Oncology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Cumulus Oncology launches new products
Congratulate Masked Content for being promoted to Masked Content at Cumulus Oncology
Check if Cumulus Oncology has recently received funding, and reach out quickly before it becomes old news!
Click to see if Cumulus Oncology had a recent Job posting/layoffs
Cumulus Oncology, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Cumulus Oncology recently announced quarterly report
Funding: Get notified immidiatlly once Cumulus Oncology has new funding data
Check out if Cumulus Oncology is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Cumulus Oncology
Compare insights from companies similar to Cumulus Oncology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Cumulus Oncology
<$5M
1-10
Private
$17.1M
2017
N/A
Company Profile Activity
Activity Insights
Cumulus Oncology is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Cumulus Oncology is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Cumulus Oncology.
Cumulus Oncology financials insights
Gather financial insights about Cumulus Oncology, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Other Financing Round
$5.6M
2024
Angel/Seed
$11.5M
Cumulus Oncology Tech Stack
A closer look at the technologies used by Cumulus Oncology
Most Recent Scoops
Executive Move
Executive Moves, Board of Directors
Funding
Funding
Funding
Cumulus Oncology News & Media
Cumulus Oncology and leadXpro Achieve Critical Milestone in GPR68 Drug Discovery Project
Small Molecules Identified for Therapeutic Intervention in Oncology and Inflammation Small Molecules Identified for Therapeutic Intervention in Oncology and InflammationCumulus Oncology Appoints Catherine Lewis La Torre to its Board of Directors
EDINBURGH, Scotland, June 10, 2024 (GLOBE NEWSWIRE) -- Cumulus Oncology, Europe’s first oncology-focused biotech company creation factory, announces the appointment of Catherine Lewis La Torre to its Board of Directors.Launch of GIO Therapeutics, founded by Cumulus Oncology, to develop therapeutics targeting G protein-coupled receptors to treat cancer and inflammation
Launch of GIO Therapeutics, founded by Cumulus Oncology, to develop therapeutics targeting G protein-coupled receptors to treat cancer and inflammationCumulus Oncology and leadXpro Announce Collaboration to Develop Small Molecules against Novel Cancer-Focused GPCR Targets
Cumulus Oncology and leadXpro Announce Collaboration to Develop Small Molecules against Novel Cancer-Focused GPCR Targets
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding Cumulus Oncology
Sign Up For FreeTo access detailed company insights
Cumulus Oncology focuses on transforming oncology drug development by creating a risk-adjusted asset portfolio aimed at improving patient outcomes. Their approach emphasizes data-driven, milestone-based decision-making to enhance the success rates of preclinical-stage assets as they progress to later stages. The company actively curates its portfol... Read More
